Keyphrases
Bisphosphonates
14%
Bone Metastasis
14%
Chemotherapy
14%
Cyclooxygenase-2 Inhibitors
14%
Docetaxel
100%
Dose Effect
14%
Drug Combination
14%
Enhanced Growth
14%
Growth Inhibition
42%
Hormonal Therapy
14%
Human Breast Cancer Cell Lines
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
57%
Human Prostate
14%
Human Tumors
28%
Induced Apoptosis
14%
Inhibition Rate
14%
Inhibitory Effect
14%
Inhibits Proliferation
14%
Less Toxic
14%
Multiple Myeloma
14%
Overexpression
14%
Proliferation Apoptosis
14%
Prostate Carcinoma
14%
Taxanes
14%
Toxic Concentration
14%
Tumor Growth
14%
Zoledronic Acid
100%
Medicine and Dentistry
4 [5 (4 Chlorophenyl) 3 Trifluoromethyl 1h Pyrazol 1 Yl]benzenesulfonamide
42%
Bisphosphonate
14%
Bone Metastasis
14%
Breast Cancer Cell Line
100%
Breast Carcinoma
14%
Cell Line
42%
Combination Drug
14%
Cyclooxygenase 2 Inhibitor
100%
Docetaxel
100%
Growth Inhibition
42%
Hormone Therapy
14%
Multiple Myeloma
14%
Neoplasm
14%
Programmed Cell Death
14%
Prostate Carcinoma
14%
Tumor Progression
14%
Zoledronic Acid
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
14%
Bone Metastasis
14%
Breast Cancer
100%
Breast Carcinoma
14%
Chemotherapy
14%
Combination Drug
14%
COX-2 Inhibitor
100%
Docetaxel
100%
Hormone Cancer Therapy
14%
Multiple Myeloma
14%
Neoplasm
14%
Prostate Carcinoma
14%
Taxane
14%
Tumor Growth
14%
Zoledronic Acid
100%
Immunology and Microbiology
Breast Cancer Cell Line
100%
Cell Line
100%
Growth Inhibition
100%
Multiple Myeloma
33%
Toxic Concentration
33%